Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Accurate Diagnosis of Influenza Critical for Better Treatment/Control

By LabMedica International staff writers
Posted on 07 Mar 2012
Patients who present with flu-like symptoms require a rapid, accurate diagnosis before they can be treated. More...


Two new metaanalyses published online in the Annals of Internal Medicine on February 21, 2012, and February 27, 2012, highlight the importance of rapid diagnosis and treatment of flu.

In the first Annals article Mudhukar Pai, MD, PhD, from the University of Alberta (Edmonton, Canada) and colleagues reviewed 159 published studies to determine the accuracy of rapid influenza diagnostic tests (RIDTs) in diagnosing flu in adults and children presenting with flu-like symptoms. In all studies, RIDTs were tested against one of two accepted reference standards.

The scientists found that RIDTs were accurate at diagnosing the flu, but not as accurate at ruling it out, meaning that patients with a negative result would need to follow up with a culture or RT-PCR. RIDTs had an approximately 13 % higher sensitivity in children compared to adults, and were more accurate at detecting the more common influenza virus A compared to influenza virus B. According to the authors, the study results support implementing RIDTs in clinical practice, especially when treating children and other patients at risk for flu-related complications.

In the second Annals study Holger Ishüneman from the Iberamerican Cochrane Center (Barcelona, Spain) and colleagues cited evidence that early treatment with antivirals (within 48 hours) may be of greater benefit than later treatment. The scientists reviewed 74 published observational studies to determine the benefits and harms of four commonly prescribed antivirals: oseltamivir, zanamivir, amantadine, and rimantadine. The investigators found that oral oseltamivir and inhaled zanamivir might provide a net benefit over no treatment for patients with known flu.

Currently used viral cultures are accurate, but turnaround from culture to lab result can take up to 10 days. Newer reverse transcriptase-polymerase chain reaction (RT-PCR) tests are much quicker than viral cultures, but are very expensive and require specialized equipment. RIDTs are inexpensive and simple to use in the physician's office. The two studies described in the Annals of Internal Medicine give more information about their advantages for diagnosing flu, and the antivirals that are most effective.

Related Links:

University of Alberta
Iberamerican Cochrane Center



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.